Kamrine E. Poels

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.

Roadmap on plasticity and epigenetics in cancer

Shannon M. Mumenthaler, H. Hatzikirou, R. Rockne, 2022, Physical biology.

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Thomas O. McDonald, Weiwei Tan, F. Michor, 2021, Nature Communications.

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia

J. Licht, A. Melnick, I. Harris, 2021, iScience.

Demographics Predict Stage III/IV Colorectal Cancer in Individuals Under Age 50

Yingzhi Qian, Peter S. Liang, Hua Zhong, 2020, Journal of clinical gastroenterology.

No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies

Yeseong Kim, R. Fass, Jiasheng Wang, 2021, Alimentary pharmacology & therapeutics.

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.